All In Biotech

Drug Trial Radar · NCT01042730

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

Last checked: Nov 20, 2026Latest source record: May 17, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 13,054 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

13,054

Actual

Start

Feb 2010

Primary completion

Jun 2016

Study completion Nov 2017

Sponsor

Lead sponsor
Juntendo UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Tokyo University; Yamaguchi University Hospital; Tohoku University; Kyoto University; Kumamoto University
First posted
Jan 6, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 20 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the prevention of cardiovascular disease by moderate cholesterol lowering therapy, pitavastatin 1mg/day or aggressive cholesterol lowering therapy, pitavastatin 4mg/day in patients with stable coronary artery disease.

Conditions

  • Coronary Artery Disease

Interventions

  • Pitavastatin 1 mg daily or 4 mg dailyDrug

    Patients who met all inclusion criteria and did not meet exclusion criteria (1) are entered in run-in period, loading pitavastatin 1 mg/day for more than 1 month when informed consent was given. (Primary registration) After 1 month, patients who did not meet exclusion criteria(2) are randomized to take pitavastatin 1 mg/day or 4 mg/day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Occurrence of one of following events(Cardiovascular death, Non-fatal Myocardial Infarction (MI), Non-fatal Cerebral Infarction (CI), Unstable angina requiring urgent hospitalization)Time frame: 3-6 years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Kyoto University Hospital

    Kyoto, Japan

  • Juntendo University School of Medicine

    Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.